Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Ends 572 Points Lower; Auto and Realty Stocks Witness Selling
Thu, 6 Dec Closing | Monish Vora, TM Team

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session on a negative note. All sectoral indices ended on a negative note with auto stocks, realty stocks, and oil & gas stocks losing the most.

At the closing bell, the BSE Sensex stood lower by 572 points (down 1.6%) and the NSE Nifty closed down by 182 points (down 1.7%). The BSE Mid Cap index ended the day down 1.5% and the BSE Small Cap index ended the day down by 1.4%.

The rupee was trading at 70.86 against the US$.

Asian stock markets finished on a negative note. As of the most recent closing prices, the Hang Seng was down by 2.5% and the Shanghai Composite was down by 1.7%. The Nikkei 225 was down 1.9%.

In the news from the commodity space, the Organization of the Petroleum Exporting Countries (OPEC) has made a planned cut in oil output effectively conditional on the contribution from non-OPEC producer Russia.

The above development comes as the group gathered in Vienna for a meeting aimed at supporting oil prices.

As per the news, the group was waiting for news from Russia as Energy Minister Alexander Novak had flown back from Vienna for a possible meeting with President Vladimir Putin.

The OPEC plus Russia and other allies are meeting on 6th and 7th December. Producers are discussing a supply curb of 1 million to 1.4 million barrels per day (bpd) and possibly more.

The OPEC meeting in Vienna will follow a gathering by the Group of 20 (G20) nations in Argentina, at which oil policy is expected to be discussed. The meet will also potentially lay the groundwork for an OPEC deal.

--- Advertisement ---
Just Do This One Thing Today…And You Could Be Set For Life

A few years ago, we published what went on to become our most popular books ever…

Equitymaster's Secrets.

With insights from our top research analysts, plus tons and tons of investing wisdom and secrets – this book is a must-read for every serious investor.

And we want you to have a virtually free copy – here's how you can claim it.

We only have 500 copies to give away, so the quicker you claim your copy, the better.

And when you do claim your copy, we also have a few surprise gifts for you…

Click here for the details.
------------------------------

Recently, Qatar announced that it is quitting next month to focus on liquefied natural gas (LNG) production. This was a big blow faced by OPEC.

Qatar's energy minister Saad Sherida al-Kaabi dismissed the notion that the move was driven by Doha's ongoing feud with OPEC's de facto leader Saudi Arabia.

Note that OPEC's de-facto leader Saudi Arabia wants the cartel and its allies to cut output by about 1.4 million barrels per day (bpd), around 1.5% of global supply.

However, while OPEC is considering withholding supply, US crude oil production reached another record high last week at 11.7 million barrels per day (bpd), according to U.S. Energy Information Administration (EIA). So, this, on the other hand, is helping cap the sharp rise in crude oil prices.

Note that high crude oil prices can be a big worry for the Modi government as well as it has been a big beneficiary of lower crude oil prices.

Also, note that India's crude oil production was lower by 4.2% in September 2018 as compared to last year.

The worrying factor is this was the lowest production this year

It's also interesting that almost every time a rise or fall in the stock markets is invariably linked to crude oil prices.

Logically, it seems right too. Rise in crude oil increases input costs for dependent firms. It also means rising inflation. Rising inflation means rising interest rates.

It also puts pressure on the government to cut excise duty, thereby impacting its revenues. We have already seen that happening. After all, there is an election year coming up.

But has it really affected the stock markets?

Here's what Girish Shetty wrote about it on one of the editions of The 5 Minute WrapUp...

  • In the short-term: Yes.

    But in the long run, as we can see, Sensex returns have been independent of crude oil prices or even positively co-related!

    Crude oil prices doubled from US$ 41 in December 2008 to US$84 in April 2010. In the same time, Sensex also doubled from 8,800 levels to 17,600 levels.

    So, please don't fret unnecessarily about crude oil.

    Check if your business has a moat that helps it pass on input price increases to its customers. In the long run, they will survive and also gain market share from those that can't pass on prices. Short term pessimism due to rising crude oil prices provides a buying opportunity in these stocks.

As per him, focusing on quality stocks rather than crude oil will matter more in the long run.

In the news from pharma space, Alembic Pharmaceuticals share price was in focus today as the company said it plans to raise up to Rs 5 billion through issue of non-convertible debentures (NCDs) on private placement basis.

The company in a filing said that its board of directors today approved the issue of unsecured listed redeemable NCDs of up to Rs 5 billion on private placement basis under a shelf disclosure document in multiple tranches.

Alembic Pharmaceuticals yesterday also announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Candesartan Cilexetil tablets USP, 4 mg, 8 mg, and 16 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Atacand Tablets, 4 mg, 8 mg, and 16 mg, of ANI Pharmaceuticals, Inc.

These tablets are indicated for the treatment of hypertension in adults and in children to lower blood pressure. They are also indicated for the treatment of heart failure.

Candesartan Cilexetil Tablets have an estimated market size of US$22 million for twelve months ending December 2017 according to IQVIA.

The company has a cumulative total of 82 ANDA approvals (69 final approvals and 13 tentative approvals) from USFDA.

To know more about the company, you can access to Alembic Pharma's Q2FY19 result analysis and Alembic Pharma's Stock Analysis on our website.

Speaking of pharma sector, note that the BSE Healthcare Index has been on a roller coaster ride in the past few years. The period from 2012 to 2015 saw the index go up more than three times.

And since then it has been a painful ride downwards, as can be seen from the chart below:

The Roller Coaster Ride of the BSE Healthcare Index

As we wrote in one of our editions of The 5 Minute WrapUp...

  • Pre-2015, pharma companies enjoyed a fairytale ride in the US market. Low labor costs, good chemistry skills, along with efficiency, ensured Indian companies could copy innovator drugs to make generic drugs at a fast pace.

    The generic business had lucrative margins for all major pharma players. But the party did not last long. In the quest to supply drugs quickly, they compromised on quality at their manufacturing facilities.

    No wonder,the US regulatory authority (USFDA) took strict action. Sun Pharma received a warning letter for its Halol manufacturing facility in 2015. It was like a bolt out of the blue. Since then, the downward spiral began and has continued till date.

We believe that pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market as well as in the overall industry.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Sensex Ends 572 Points Lower; Auto and Realty Stocks Witness Selling". Click here!

  

Stock Market Updates

ASHOKA BUILDCON Share Price Up by 5%; BSE REALTY Index Down 1.1% (Today's Market)

Aug 3, 2020 03:23 PM

ASHOKA BUILDCON share price is trading up by 5% and its current market price is Rs 53. The BSE REALTY is down by 1.1%. The top gainers in the BSE REALTY Index is ASHOKA BUILDCON (up 5.1%). The top losers are GODREJ PROPERTIES (down 0.3%) and PHOENIX MILL (down 1.6%).

ADVANCED ENZYME TECHNOLOGIES Share Price Up by 12%; BSE HEALTHCARE Index Up 0.9% (Today's Market)

Aug 3, 2020 02:37 PM

ADVANCED ENZYME TECHNOLOGIES share price is trading up by 12% and its current market price is Rs 212. The BSE HEALTHCARE is up by 0.9%. The top gainers in the BSE HEALTHCARE Index are ADVANCED ENZYME TECHNOLOGIES (up 11.6%) and BLISS GVS PHARMA (up 14.4%). The top losers are CIPLA (down 1.0%) and FORTIS HEALTHCARE (down 1.1%).

STERLITE TECH. Share Price Down by 5%; BSE 500 Index Down 0.9% (Today's Market)

Aug 3, 2020 02:37 PM

STERLITE TECH. share price is trading down by 5% and its current market price is Rs 123. The BSE 500 is down by 0.9%. The top gainers in the BSE 500 Index are BLISS GVS PHARMA (up 14.4%) and JUBILANT LIFE SCIENCES (up 9.7%). The top losers are STERLITE TECH. (down 5.1%) and APOLLO HOSPITALS (down 5.2%).

GUJARAT GAS Share Price Up by 5%; BSE OIL & GAS Index Down 0.6% (Today's Market)

Aug 3, 2020 02:27 PM

GUJARAT GAS share price is trading up by 5% and its current market price is Rs 304. The BSE OIL & GAS is down by 0.6%. The top gainers in the BSE OIL & GAS Index is GUJARAT GAS (up 5.1%). The top losers are CASTROL INDIA and INDRAPRASTHA GAS (down 1.1%).

APOLLO HOSPITALS Share Price Down by 5%; BSE 500 Index Down 1.0% (Today's Market)

Aug 3, 2020 02:11 PM

APOLLO HOSPITALS share price is trading down by 5% and its current market price is Rs 1,702. The BSE 500 is down by 1.0%. The top gainers in the BSE 500 Index are BLISS GVS PHARMA (up 10.1%) and JUBILANT LIFE SCIENCES (up 10.0%). The top losers are APOLLO HOSPITALS (down 5.4%) and UPL (down 5.4%).

Sensex Slips Over 400 Points; Kotak Mahindra Bank & IndusInd Bank Top Losers (Today's Market)

Aug 3, 2020 12:30 pm

The BSE Sensex is trading down by 397 points, while the NSE Nifty is trading down by 103 points.

View More Indian Share Market News

Most Popular

Why the Stock of HDFC Bank Deserves a Closer Look than Before...(Profit Hunter)

Jul 22, 2020

HDFC Bank's results point to a gaping hole in Indian financial sector. Possibly even a global contagion.

My Best Trading Ideas When Interest Rates Are So Low(Fast Profits Daily)

Jul 23, 2020

India's interest rates are lower than the inflation rate. Here are the best trades for this situation.

The Smallcap Stock that Made Me Change My Asset Allocation Rule(Profit Hunter)

Jul 21, 2020

I believe this smallcap niche leader could deliver a non-linear payoff.

Gold or Silver: Which One Should You Buy Now?(Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Aug 3, 2020 (Close)

MARKET STATS